0001193125-20-286672.txt : 20201211 0001193125-20-286672.hdr.sgml : 20201211 20201105141452 ACCESSION NUMBER: 0001193125-20-286672 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20201105 FILER: COMPANY DATA: COMPANY CONFORMED NAME: InMed Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001728328 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: SUITE 310, 815 W. HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1B4 BUSINESS PHONE: (604) 669-7207 MAIL ADDRESS: STREET 1: SUITE 310, 815 W. HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1B4 CORRESP 1 filename1.htm CORRESP

Roth Capital Partners, LLC

888 San Clemente Drive

Newport Beach, CA 92660

November 5, 2020

Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

 

  Re:

InMed Pharmaceuticals Inc. (the “Company”)

Registration Statement on Form S-1 (File No. 333-239319)

Ladies and Gentlemen:

In connection with the above-captioned registration statement, and pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), Roth Capital Partners, LLC, as the representative of the underwriters, hereby joins in the request of the Company that the effective date of such registration statement be accelerated to 5:00 p.m. (Eastern time) on Monday, November 9, 2020, or as soon thereafter as practicable.

In making this request the undersigned acknowledges that it is aware of its obligations under the Act as they relate to the public offering of securities pursuant to the registration statement.

[Signature Page Follows]

Very truly yours,

 

ROTH CAPITAL PARTNERS, LLC,
As the Representative of the Underwriters
By:   /s/ Aaron M. Gurewitz
Name:   Aaron M. Gurewitz
Title:   Head of Equity Capital Markets